Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study

por Huang, Chunlong, Gu, Xiaoyuan, Zeng, Xianshang, Chen, Baomin, Yu, Weiguang, Chen, Meiji
Publicado 2021